| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | FT24ZQQ5RP |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Mannan-binding lectin serine protease 2 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Atypical Hemolytic Uremic Syndrome | 3 | D065766 | ClinicalTrials |
| Lupus Nephritis | 2 | D008181 | ClinicalTrials |
| Severe Acute Respiratory Syndrome | 2 | D045169 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298195 |
| FDA SRS | FT24ZQQ5RP |
CONTENTS